Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,596.00
Bid: 12,592.00
Ask: 12,596.00
Change: 6.00 (0.05%)
Spread: 4.00 (0.032%)
Open: 12,626.00
High: 12,646.00
Low: 12,474.00
Prev. Close: 12,590.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Sterling hits 2-1/2-month high on vaccine and Brexit deal optimism

Mon, 23rd Nov 2020 09:45

* Pound hits 2-1/2-month high vs dollar

* Forecast-beating PMIs support sterling

* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh

* Graphic: Trade-weighted sterling since Brexit vote http://tmsnrt.rs/2hwV9Hv
(Adds new quote, latest prices)

LONDON, Nov 23 (Reuters) - Sterling rallied on Monday,
briefly touching a 2-1/2-month high, as more positive news about
a potential COVID-19 vaccine propelled investors to buy riskier
currencies and investors bet Britain and the European Union
would clinch a Brexit trade deal.

London and Brussels this week continue their negotiations to
agree a deal on their future trading relationship, though time
is now running very short as Britain's post-Brexit transition
period ends in fewer than six weeks.

Without an agreement Britain would revert to trading with
the EU on World Trade Organisation rules, an outcome both sides
believe would prove highly disruptive for their economies.

Most investors believe a deal will be clinched, even if it
is a bare-bones one that leaves some trade discussions for
later.

News on Monday that AstraZeneca's vaccine for the novel
coronavirus could be around 90% effective added to the positive
mood.

The British currency rose 0.8% to as high as $1.3396
, its strongest since early September, before the gains
faded in late London trading. It last stood at $1.3304.

Against the euro it rose more than half a percent to 88.68
pence, a near two-week high.

"There is scope for a relief rally in GBP on news that a
deal has been signed, though the failure of the UK and EU to
agree a comprehensive deal will likely limit upside potential,"
said Rabobank strategist Jane Foley, noting that a limited,
"skeleton" trade deal had been priced in to the pound.

"Since the scenario described above is a consensus view,
there is greater scope for volatility in EUR/GBP if a deal is
not struck. This is still possible," she added.

Ulrich Leuchtmann, an FX strategist at Commerzbank, said an
extension to the Dec. 31 transition period end-date is now
likely as the two sides run out of time to forge a deal.

"The FX market is seeing it as a GBP positive sign that the
negotiations are being continued in December," he said.

The widely watched flash purchasing managers index (PMI
surveys for November came in better than expected, with the
composite measure touching 47.4 against a forecast of 42.5.
However, any reading below 50 still represents a contraction,
and the latest lockdown measures are weighing on the economy.

In a busy week for the UK, Finance Minister Rishi Sunak will
unveil his spending review on Wednesday. He vowed over the
weekend that there would be no return to austerity, even as the
coronavirus crisis pushes Britain's debt further above 2
trillion pounds.

(Reporting by Tommy Wilkes;
Editing by Gareth Jones and Andrea Ricci)

More News
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more
26 Dec 2023 21:26

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 21:00

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 19:41

Wall Street gains on final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
22 Dec 2023 08:47

AstraZeneca, Ionis get US FDA nod for Wainua in "important milestone"

(Alliance News) - AstraZeneca PLC and Ionis Pharmaceuticals Inc on Friday celebrated the news that their drug eplontersen was approved by the US Food & Drug Administration.

Read more
22 Dec 2023 07:50

LONDON BRIEFING: UK on brink of recession as economy contracts in Q3

(Alliance News) - Stocks in London are likely to open lower on Friday, with investors feeling frosty ahead of a US inflation print this afternoon, amid sobering UK economic growth data.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.